Alzheimer’s disease (AD) is an incurable neurodegenerative disease and the most common form of dementia. Research is ongoing to better understand AD pathogenesis and explore potential treatments. Genome editing tools like CRISPR/Cas9 offer new approaches to study and potentially treat AD. Key Facts: AD pathogenesis likely involves multiple genetic and environmental factors Gene mutations linked …
While people will always be in search of specific diets to help them lose weight, in recent years there is an increasing interest in how certain foods affect the human brain. It is estimated that there are currently over 5 million individuals in the United States that have been diagnosed with Alzheimer’s disease, and dietary …
Namenda (Memantine) is a drug that was approved by the FDA in 2003 for the treatment of Alzheimer’s disease. Research suggests that Namenda has a small effect in reducing symptoms among those diagnosed with moderate or severe cases of Alzheimer’s. It appears to have no significant effect when administered to individuals diagnosed with milder cases …
Do you speak multiple languages? If not, there some research suggesting that you may want to start. Research from the University of Edinburgh in the United Kingdom revealed that individuals who are bilingual tend to have delayed onsets of dementia. Dementia is regarded as a specific genre of brain disorders characterized by impairments in cognition, …